Ana Carrero-Fernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ana Carrero-Fernández has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Adelina Gonzalez
Anesthesiology Department, Hospital Universitario Infanta Sofia, 28702 Madrid, Spain
1 shared publication Alba Mulet
Hospital Clínico Universitario , Incliva, Universidad de Valencia, Valencia
1 shared publication- Antonio Fernández-Ortiz
Cardiovascular Institute, Hospital Clínico San Carlos, 28040 Madrid, Spain
1 shared publication - Carlos Macaya
Universidad Complutense de Madrid
1 shared publication - Charbel Maroun Eid
Hospital Universitario La Paz , Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid
1 shared publication - Christoph Liebetrau
Department of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany
1 shared publication
Latest Publications
- Open Access
- 17 November 2020
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 50 (2) , 326-334
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
The coronavirus disease 2019 (COVID-19) is characterized by poor outcomes and mortality, particularly in older patients. Post-hoc analysis of the international, multicentre, “real-world” HOPE COVID-19 registry. All patients aged ≥65 years hospitalised for COVID-19 were selected. Epidemiological, clinical, analytical and outcome data were obtained. A comparative study between two age subgroups, 65–74 and ≥75 years, was performed. The primary endpoint was all cause in-hospital mortality. 1,520 patients aged ≥65 years (60.3% male, median age of 76 [IQR 71–83] years) were included. Comorbidities such as hypertension (69.2%), dyslipidemia (48.6%), cardiovascular diseases (any chronic heart disease in 38.4% and cerebrovascular disease in 12.5%), and chronic lung disease (25.3%) were prevalent, and 49.6% were on ACEI/ARBs. Patients aged 75 years and older suffered more in-hospital complications (respiratory failure, heart failure, renal failure, sepsis) and a significantly higher mortality (18.4 vs. 48.2%, P < 0.001), but fewer admissions to intensive care units (11.2 vs. 4.8%). In the overall cohort, multivariable analysis demonstrated age ≥75 (OR 3.54), chronic kidney disease (OR 3.36), dementia (OR 8,06), peripheral oxygen saturation at admission <92% (OR 5.85), severe lymphopenia (1 (OR 8.31) to be independent predictors of mortality. Patients aged ≥65 years hospitalised for COVID-19 had high rates of in-hospital complications and mortality, especially among patients 75 years or older. Age ≥75 years, dementia, peripheral oxygen saturation 1 were independent predictors of mortality in this population.
- 17 November 2020
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 50 (2) , 326-334
Open AccessClinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
The coronavirus disease 2019 (COVID-19) is characterized by poor outcomes and mortality, particularly in older patients. Post-hoc analysis of the international, multicentre, “real-world” HOPE COVID-19 registry. All patients aged ≥65 years hospitalised for COVID-19 were selected. Epidemiological, clinical, analytical and outcome data were obtained. A comparative study between two age subgroups, 65–74 and ≥75 years, was performed. The primary endpoint was all cause in-hospital mortality. 1,520 patients aged ≥65 years (60.3% male, median age of 76 [IQR 71–83] years) were included. Comorbidities such as hypertension (69.2%), dyslipidemia (48.6%), cardiovascular diseases (any chronic heart disease in 38.4% and cerebrovascular disease in 12.5%), and chronic lung disease (25.3%) were prevalent, and 49.6% were on ACEI/ARBs. Patients aged 75 years and older suffered more in-hospital complications (respiratory failure, heart failure, renal failure, sepsis) and a significantly higher mortality (18.4 vs. 48.2%, P < 0.001), but fewer admissions to intensive care units (11.2 vs. 4.8%). In the overall cohort, multivariable analysis demonstrated age ≥75 (OR 3.54), chronic kidney disease (OR 3.36), dementia (OR 8,06), peripheral oxygen saturation at admission <92% (OR 5.85), severe lymphopenia (1 (OR 8.31) to be independent predictors of mortality. Patients aged ≥65 years hospitalised for COVID-19 had high rates of in-hospital complications and mortality, especially among patients 75 years or older. Age ≥75 years, dementia, peripheral oxygen saturation 1 were independent predictors of mortality in this population.